These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10212758)

  • 1. Accuracy of cefepime antimicrobial susceptibility testing results for Pseudomonas aeruginosa tested on the MicroScan WalkAway System.
    Biedenbach DJ; Marshall SA; Jones RN
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):305-7. PubMed ID: 10212758
    [No Abstract]   [Full Text] [Related]  

  • 2. Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.
    Sader HS; Fritsche TR; Jones RN
    J Clin Microbiol; 2006 Mar; 44(3):1101-4. PubMed ID: 16517904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracies of beta-lactam susceptibility test results for Pseudomonas aeruginosa with four automated systems (BD Phoenix, MicroScan WalkAway, Vitek, and Vitek 2).
    Juretschko S; Labombardi VJ; Lerner SA; Schreckenberger PC;
    J Clin Microbiol; 2007 Apr; 45(4):1339-42. PubMed ID: 17229867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of inoculum density prepared by prompt inoculation system and antimicrobial susceptibility test results by the automated MicroScan WalkAway system].
    Nakasone I; Higa M; Furugen F; Yamane N
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 1999 Dec; 10(2):83-9. PubMed ID: 10681710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime.
    Alyaseen SA; Piper KE; Rouse MS; Steckelberg JM; Patel R
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2543-5. PubMed ID: 15917569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of workflow and accuracy of identification and antimicrobial susceptibility testing of clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and enterococci by Vitek 2 and routine methods.
    Rantakokko-Jalava K; Elo-Lehtonen E; Meurman O
    APMIS; 2006 Jan; 114(1):43-9. PubMed ID: 16499660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime.
    Jones RN; Biedenbach DJ; Marshall SA; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1998 Oct; 32(2):107-10. PubMed ID: 9823533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime activity against Pseudomonas aeruginosa: evaluation of Etest and two disc diffusion methods.
    Stes P; Goossens H
    J Antimicrob Chemother; 1996 Oct; 38(4):707-11. PubMed ID: 8937965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of the BD phoenix automated microbiology system in meropenem susceptibility testing of clinical Pseudomonas aeruginosa isolates.
    Bayramoglu G; Acuner IC; Sinirtas M; Gedikoglu S; Durupinar B
    Saudi Med J; 2006 Dec; 27(12):1921-3. PubMed ID: 17143380
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of Proteus species and Pseudomonas aeruginosa to penicillins and cephalosporins.
    Adler JL; Burke JP; Wilcox C; Finland M
    Antimicrob Agents Chemother (Bethesda); 1970; 10():63-7. PubMed ID: 5000270
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
    Sader HS; Jones RN
    Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.
    Foweraker JE; Laughton CR; Brown DF; Bilton D
    J Antimicrob Chemother; 2005 Jun; 55(6):921-7. PubMed ID: 15883175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of resistance of Pseudomonas aeruginosa isolates to select antibiotics].
    Sekowska A; Janicka G; Wojda M; Wróblewska J; Manysiak S
    Pol Merkur Lekarski; 2005 Aug; 19(110):169-71. PubMed ID: 16245425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three standardized disc susceptibility testing methods for colistin.
    Tan TY; Ng LS
    J Antimicrob Chemother; 2006 Oct; 58(4):864-7. PubMed ID: 16905528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
    Chin JN; Jones RN; Sader HS; Savage PB; Rybak MJ
    J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-lactam antibiotics on the in vitro development of resistance in Pseudomonas aeruginosa.
    Carsenti-Etesse H; Cavallo JD; Roger PM; Ziha-Zarifi I; Plesiat P; Garrabe E; Dellamonica P
    Chirurgia (Bucur); 2002; 97(2):151-9. PubMed ID: 12731225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of the Vitek automated system with cards GNS 122 and 127 and VTK-R07.01 software for antimicrobial susceptibility testing of Pseudomonas aeruginosa.
    Chandler LJ; Poulter M; Reisner B; Woods G
    Diagn Microbiol Infect Dis; 2002 Jan; 42(1):71-3. PubMed ID: 11821175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa.
    Al-Jasser AM; Elkhizzi NA
    Saudi Med J; 2004 Jun; 25(6):780-4. PubMed ID: 15195211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.